493. From Data Science to Drug Design: How AI Shifts Discovery, Target Validation, and Portfolio Construction (Jim Tananbaum)

The Full Ratchet (TFR): Venture Capital and Startup Investing Demystified · Oct 6, 2025 · 39m

Jim Tananbaum of Foresite Capital joins Nick to discuss From Data Science to Drug Design: How AI Shifts Discovery, Target Validation, and Portfolio Construction. In this episode we cover:

Data Science and Investment Approach

Investment Practices and Market Conditions

China's Role in Biotech and Regulatory Considerations

Impact of AI on Biotech and Healthcare

Healthcare Adoption of AI and Preventive Measures

Payers and Insurance Companies' Role

Lessons from Successful Investments

Generating Liquidity in a Sluggish Market

Future of GLP-1 Agonists

Guest Links:

Jim's LinkedIn

Jim's X

Foresite's…